2019
DOI: 10.1002/biof.1501
|View full text |Cite
|
Sign up to set email alerts
|

Cardioprotective effects of omega‐3 fatty acids and ascorbic acid improve regenerative capacity of embryonic stem cell‐derived cardiac lineage cells

Abstract: One of the major issues in cell therapy of myocardial infarction (MI) is early death of engrafted cells in a harsh oxidative stress environment, which limits the potential therapeutic utility of this strategy in the clinical setting. Increasing evidence implicates beneficial effects of omega-3 fatty acids including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) Abbreviations: AA, ascorbic acid; ANOVA, analysis of variance; ARE, antioxidant response element; bFGF, basic fibroblast growth factor; BSA… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
9
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 13 publications
(9 citation statements)
references
References 69 publications
0
9
0
Order By: Relevance
“…The development of scaffold-based cell delivery techniques is in the early stages for cardiac tissue engineering, and there are still opportunities to incorporate additional treatments to modulate the antioxidative and anti-inflammatory process. Pharmacological pretreatments (such as omega-3 fatty acids and cobalt protoporphyrin) have beneficent effects on survival of ESC-CMs as evidenced by upregulation of HO-1 and decreased ROS levels under oxidative or hypoxic conditions [ 151 , 152 ]. Future study will reveal new targets and pharmacological compounds to enhance cell engraftment of EHTs after delineating the mechanisms by which the fate of transplanted cells is mediated by increased ROS or downregulated endogenous antioxidant system.…”
Section: Convergences Of Antioxidants and Cell-based Therapymentioning
confidence: 99%
“…The development of scaffold-based cell delivery techniques is in the early stages for cardiac tissue engineering, and there are still opportunities to incorporate additional treatments to modulate the antioxidative and anti-inflammatory process. Pharmacological pretreatments (such as omega-3 fatty acids and cobalt protoporphyrin) have beneficent effects on survival of ESC-CMs as evidenced by upregulation of HO-1 and decreased ROS levels under oxidative or hypoxic conditions [ 151 , 152 ]. Future study will reveal new targets and pharmacological compounds to enhance cell engraftment of EHTs after delineating the mechanisms by which the fate of transplanted cells is mediated by increased ROS or downregulated endogenous antioxidant system.…”
Section: Convergences Of Antioxidants and Cell-based Therapymentioning
confidence: 99%
“…Incubation with this bioactive lipid cocktail before hydrogen peroxide treatment increases the expression of cardiomyocyte markers, decreases the expression of fibroblast markers, and reduces the production of harmful reactive oxygen species. It is also notable that these oxylipins reduce the accumulation of fibrosis after myocardial infarction in ischemic rat hearts [ 189 ]. One particular area of study that is generating much interest is the beneficial pro-resolution of inflammation mediated by docosanoids.…”
Section: Recent Advances In Bioactive Lipids In Cardiac Diseasementioning
confidence: 99%
“…In clinical trials, high-dose EPA (4 g/day) reduced the incidences of clinical events by 25% in statin-treated patients with established CVD or diabetes and other cardiovascular risk factors [193]. The cardioprotective effect of omega-3 fatty acids and ascorbic acid improves the regenerative capacity of embryonic stem cell-derived cardiac lineage cells [194]. Pre-incubation of cells with EPA + DHA + AA before H 2 O 2 treatment weakened the production of reactive oxygen species (ROS), improved cell viability and increased HO-1 and CX43 (connexin43) expression, leading to a marked rise in cardiac troponin (TNNT2) positive cells and a decrease in vimentin-positive cells [194].…”
Section: Therapeutic Effects Of Dhpa and Epa On Cardiac Fibrosismentioning
confidence: 99%
“…The cardioprotective effect of omega-3 fatty acids and ascorbic acid improves the regenerative capacity of embryonic stem cell-derived cardiac lineage cells [194]. Pre-incubation of cells with EPA + DHA + AA before H 2 O 2 treatment weakened the production of reactive oxygen species (ROS), improved cell viability and increased HO-1 and CX43 (connexin43) expression, leading to a marked rise in cardiac troponin (TNNT2) positive cells and a decrease in vimentin-positive cells [194]. In particular, the injection of EPA + DHA + AA pretreated ESC (embryonic stem cell)-derived cardiac lineage cells into the ischemic myocardium of the MI rat model significantly reduced fibrosis compared to the vehicle group [194].…”
Section: Therapeutic Effects Of Dhpa and Epa On Cardiac Fibrosismentioning
confidence: 99%